During the past decade, Perinatal HIV Research Unit conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Perinatal HIV Research Unit" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "HIV Vaccine Trials Network" with 2 trials sponsored, "Kirby Institute" with 2 trials sponsored and "PENTA Foundation" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Perinatal HIV Research Unit" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials as a collaborator, "HIV Vaccine Trials Network" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Bio Analytical Research Corporation" with 2 trials as a collaborator and "BioVac" with 2 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Perinatal HIV Research Unit" are "HIV Infections" (7 trials), "HIV Infection" (6 trials), "Tuberculosis" (3 trials), "HIV-1 Infection" (2 trials) and "Acquired Immune Deficiency Syndrome (AIDS)" (1 trials). Many other conditions were trialed in "Perinatal HIV Research Unit" in a lesser frequency.

Most popular intervention types in "Perinatal HIV Research Unit" are "Biological" (10 trials), "Drug" (9 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.COV2.S" (3 trials), "ALVAC-HIV" (2 trials), "Placebo" (2 trials), "AERAS-402 1.0 x 10^11 vp" (1 trials) and "AERAS-402 1.5 x 10^10 vp" (1 trials). Other intervention names were less common.

The vast majority of trials in "Perinatal HIV Research Unit" are 20 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Perinatal HIV Research Unit". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Perinatal HIV Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Perinatal HIV Research Unit, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".